Page last updated: 2024-09-05

lenalidomide and HIV Coinfection

lenalidomide has been researched along with HIV Coinfection in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's7 (46.67)24.3611
2020's7 (46.67)2.80

Authors

AuthorsStudies
Aboulafia, D; Ambinder, RF; Baiocchi, R; Bui, JD; Chiao, EY; Dittmer, DP; Han, S; Martínez-Maza, O; Maurer, T; Mitsuyasu, R; Moore, P; Reid, EG; Shimabukuro, K; Wachsman, W1
Henry, DH; Maki, RG1
Kodad, SG; Sabry, W; Wu, Y1
Guo, Y; Hang, Y; Hui, J; Liu, X; Peng, X; Tao, R; Wan, Z; Zhu, B; Zhu, X1
Guo, Y; Huang, Y; Hui, J; Liu, X; Peng, X; Tao, R; Wan, Z; Zhu, B; Zhu, X1
Lin, X; Wang, J; Wang, X; Wen, Y; Yan, X; Zhou, Y1
Chen, J; Liu, L; Qi, T; Song, W; Sun, J; Tang, Y; Wang, Z; Xu, S; Yang, J; Zhang, R1
Kobayashi, Z1
Sato, S1
Assoumou, L; Boué, F; Cardon, F; Chennebault, JM; Costagliola, D; Curjol, A; Desnoyer, A; Gibowski, S; Lebbe, C; Marcelin, AG; Peytavin, G; Poizot-Martin, I; Pourcher, V; Salmon, D1
Blum, S; Cavassini, M; Fayet, A; Jotterand, M; Lambert, JF; Schapira, M1
Alba, L; Antinori, A; Bibas, M; Del Nonno, F; Grisetti, S; Picchi, G1
Aerts, JL; Allard, SD; De Keersmaecker, B; Lacor, P; Schots, R; Thielemans, K1
Deeks, SG; Ferrucci, L; Goetzl, EJ; Greig, N; Hesdorffer, CS; Kane, L; Lim, H; Schwartz, JB1
Hanekom, WA; Haslett, PA; Kaplan, G; Muller, G1

Trials

1 trial(s) available for lenalidomide and HIV Coinfection

ArticleYear
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
    AIDS research and human retroviruses, 2017, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Lenalidomide; Male; Middle Aged; Sarcoma, Kaposi; Thalidomide; Treatment Outcome; Young Adult

2017

Other Studies

14 other study(ies) available for lenalidomide and HIV Coinfection

ArticleYear
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 06-13, Volume: 28, Issue:12

    Topics: Cytokines; Herpesvirus 8, Human; HIV Infections; Humans; Lenalidomide; Sarcoma, Kaposi

2022
Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 06-13, Volume: 28, Issue:12

    Topics: HIV Infections; Humans; Lenalidomide; Sarcoma, Kaposi

2022
Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.
    Current oncology (Toronto, Ont.), 2022, 07-18, Volume: 29, Issue:7

    Topics: Bortezomib; Dexamethasone; HIV Infections; Humans; Lenalidomide; Neoplasm Recurrence, Local; Plasmablastic Lymphoma

2022
Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot study.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Cytokines; HIV Infections; HIV-1; Humans; Inflammation; Interleukin-6; Lenalidomide; Leukocytes, Mononuclear; Meningitis, Cryptococcal; Pilot Projects; RNA, Viral; Tumor Necrosis Factor-alpha

2022
Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
    Journal of neuroinflammation, 2023, Feb-15, Volume: 20, Issue:1

    Topics: Albumins; HIV; HIV Infections; Humans; Inflammation; Lenalidomide; Meningitis, Cryptococcal; Prospective Studies

2023
Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report.
    AIDS research and therapy, 2023, 08-29, Volume: 20, Issue:1

    Topics: Agammaglobulinaemia Tyrosine Kinase; Central Nervous System; HIV; HIV Infections; Humans; Lenalidomide; Lymphoma

2023
Zanubrutinib, lenalidomide, and rituximab (ZR2 regimen) for HIV-associated diffuse large B-cell lymphoma: a real-world analysis from China.
    AIDS (London, England), 2023, 10-01, Volume: 37, Issue:12

    Topics: China; HIV Infections; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Rituximab

2023
Did This Cryptococcosis Patient Have HIV Coinfection?
    Internal medicine (Tokyo, Japan), 2019, 12-15, Volume: 58, Issue:24

    Topics: Antibodies, Monoclonal; Cryptococcosis; Dexamethasone; HIV Infections; Humans; Lenalidomide; Multiple Myeloma

2019
The Author's Reply to "Did This Cryptococcosis Patient Have HIV Coinfection?"
    Internal medicine (Tokyo, Japan), 2019, 12-15, Volume: 58, Issue:24

    Topics: Antibodies, Monoclonal; Cryptococcosis; Dexamethasone; HIV Infections; Humans; Lenalidomide; Multiple Myeloma

2019
Treatment of 5q-syndrome with lenalidomide in an HIV-positive patient under cART.
    Annals of hematology, 2010, Volume: 89, Issue:4

    Topics: Anti-HIV Agents; Chromosome Deletion; Chromosomes, Human, Pair 5; Drug Therapy, Combination; HIV Infections; Humans; Lenalidomide; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Thalidomide

2010
Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-01, Volume: 28, Issue:34

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Boronic Acids; Bortezomib; Cytarabine; Deoxycytidine; Dexamethasone; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lenalidomide; Lymphoma, Large-Cell, Immunoblastic; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Pyrazines; Recombinant Proteins; Thalidomide; Young Adult

2010
Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.
    Journal of virology, 2012, Volume: 86, Issue:17

    Topics: CD8-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Electroporation; gag Gene Products, Human Immunodeficiency Virus; HIV Infections; HIV-1; Humans; Immunologic Factors; Lenalidomide; nef Gene Products, Human Immunodeficiency Virus; RNA, Messenger; Species Specificity; Thalidomide

2012
Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.
    Clinical and experimental immunology, 2012, Volume: 169, Issue:2

    Topics: Adult; CD4-CD8 Ratio; Chemotaxis; HIV Infections; Humans; Interleukin-2; Lenalidomide; Male; Middle Aged; T-Lymphocytes; T-Lymphocytopenia, Idiopathic CD4-Positive; Thalidomide

2012
Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro.
    The Journal of infectious diseases, 2003, Mar-15, Volume: 187, Issue:6

    Topics: Adjuvants, Immunologic; CD8-Positive T-Lymphocytes; Cell Division; Coculture Techniques; Cytokines; Cytomegalovirus Infections; Dendritic Cells; Dose-Response Relationship, Immunologic; Flow Cytometry; HIV Infections; Humans; Immunosorbent Techniques; Lenalidomide; Thalidomide

2003